证券记录 · 已归档季度
ADMA
ADMA Biologics, Inc. · Healthcare · Biotechnology
13被追踪持有人
—Δ持有人
23.97M持有股份
$268.00M报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 107 | -1 | 146.21M | $1.22B | +9 | −10 |
| Q1 2026 | 111 | -5 | 163.83M | $1.48B | +7 | −12 |
| Q4 2025 | 115 | +1 | 163.64M | $2.98B | +1 | — |
| Q3 2025 | 19 | +1 | 92.34M | $1.35B | +3 | −3 |
| Q2 2025 | 16 | -1 | 89.41M | $1.63B | +1 | −2 |
| Q1 2025 | 14 | 0 | 31.71M | $629.12M | — | — |
| Q4 2024 | 14 | +2 | 37.00M | $634.64M | +2 | — |
| Q3 2024 | 11 | -2 | 23.86M | $476.89M | — | −2 |
| Q2 2024 | 13 | — | 23.97M | $268.00M | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | D. E. Shaw & Co. ✦ | 6.82M | — | $76.30M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | D. E. Shaw & Co. ✦ | 6.82M | — | $76.30M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 5.24M | — | $58.64M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 5.24M | — | $58.64M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Two Sigma Investments ✦ | 4.03M | — | $45.03M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 2.58M | — | $28.87M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 2.08M | — | $23.21M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 2.08M | — | $23.21M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Millennium Management ✦ | 940.65K | — | $10.52M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 773.41K | — | $8.65M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 773.41K | — | $8.65M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 773.41K | — | $8.65M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 665.06K | — | $7.43M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Wellington Management ✦ | 598.23K | — | $6.69M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Wellington Management ✦ | 598.23K | — | $6.69M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Point72 Asset Management ✦ | 103.45K | — | $1.16M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 78.15K | — | $873,695 | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 30.35K | — | $339,324 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Marshall Wace ✦ | 26.80K | — | $299,624 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 355 持有人, 211.31M 股份, $1.84B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据